Search results
Rising rates of hypertension driving growth in cardiac drugs market
Business Today· 12 hours agoThe growth rate of the market value of anti-hypertensives recorded fluctuations over the years but...
Childhood and midlife stress could increase risk of developing Alzheimer’s
Scroll· 1 day agoStressful life events, such as the death of a loved one or divorce, put a person at greater risk of developing dementia in later life, a recent study has found. The study, published in Annals ...
IIPE, Vizag research finds eco-friendly solution for treatment of muddy river water
The Hindu· 3 days agoResearchers of Assam Science and Technology University in Guwahati, Gauhati University, Pragjyotish...
Delhi sees hottest day of season at 42.5 deg Celsius; IMD sounds red alert
Business Standard India· 2 hours agoThe national capital on Saturday recorded the this season's hottest day so far with the mercury...
13-year-old girl fights Wilson's disease, liver failure & hepatitis A to live
Daiji World· 2 days agoNew Delhi, May 16 (IANS): In a case of medical marvel, a 13-year-old girl has fought all odds...
British device manufacturer Entaco secures £1m investment following buyout
Medical Device Network· 1 day agoand manufacturing sectors in March 2024. The package includes £7.5m to support two pharmaceutical...
BMS reports four-year data from psoriasis treatment extension trial
Clinical Trials Arena· 1 day agoThe efficacy outcomes were sustained, with continuous treatment yielding stable PASI 75, PASI 90, ...
UoH and NIN scientists study obesity-linked kidney ailment
The Hindu· 2 days agoResearch explores obesity-induced kidney injury, proteinuria, and WT1 reactivation as a potential target for prevention and treatment.
Crowdfunding Raises Rs 17.5 Crore For Treatment Of 23-Month-Old Boy Suffering From SMA
Indiatimes· 3 days agoThe crowdfunding was launched in February this year to raise funds for the treatment of Hridayansh...
NHS introduces Pfizer’s tafamidis for ATTR-CM treatment
Pharmaceutical Technology· 4 days agoIn May 2024 the NHS announced plans to offer Pfizer‘s Voxelotor (Oxbryta), a new treatment option...